Search for instruments
Ryvu Therapeutics SA
Ryvu Therapeutics SA is a biotech firm that specializes in developing innovative cancer therapies. The company is based in Poland and is committed to advancing the field of oncology by leveraging its expertise in drug discovery, preclinical development, and clinical research. Ryvu Therapeutics SA's pipeline includes small molecule and antibody-based therapies that target key pathways involved in cancer growth and progression. Its lead candidate, SEL120, is a potent and selective CDK8/19 inhibitor that has shown promising results in preclinical studies. The company is dedicated to bringing new treatments to cancer patients and improving outcomes for those affected by this devastating disease.Instrument specification in OANDA
Name
Ryvu Therapeutics SA
Currency
PLN
Symbol
RVU.PL
Minimum order value
1
Ticker
RVU
Trading hours
monday-friday 09:00-16:50
Type
Stocks Poland
Hours of accepting orders
monday-friday 07:00-16:50, 18:00-22:00
ISIN
PLSELVT00013
Start trading now with fast account opening.
Sign-up now to trade the most active markets
Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
